{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-053412","form_type":"8-K","ticker":"STE","cik":"0001757898","company_name":"STERIS plc","filed_at":"2026-08-05T20:33:00+00:00","discovered_at":"2026-08-05T20:34:00.323443+00:00","generated_at":"2026-08-05T20:34:32.169207+00:00","sec_items":["2.02","2.05","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"STERIS Q1 revenue $1.5B (+7%), adj EPS $2.59; announces $55-70M restructuring plan","bullets":["Revenue $1.5B (+7% YoY); constant currency organic growth 6%. Adjusted EPS $2.59 vs $2.34 prior year.","Healthcare segment revenue $1.05B (+8%); AST $297.6M (+6%); Life Sciences $146.7M (+9%).","Operating cash flow $367.1M (down from $420M); free cash flow $279.6M (down from $326.5M).","Restructuring: consolidation of chemistries to NC Center of Excellence; closure of St. Louis and Plymouth facilities; pre-tax charges $55-70M, completion by fiscal 2030.","FY2027 guidance reaffirmed: revenue growth 7-8%, adj EPS $11.10-$11.30; CapEx raised to ~$450M, FCF now ~$800M."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-053412","json":"https://secwatch.observer/filing/0001628280-26-053412.json","markdown":"https://secwatch.observer/filing/0001628280-26-053412.md","text":"https://secwatch.observer/filing/0001628280-26-053412.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1757898/000162828026053412/0001628280-26-053412-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1757898/000162828026053412/ste-20260805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-05T20:34:32.169207+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}